Probius

Phenotyping biology at the quantum level
#deeptech

[Probius @probiusbio]

It's the last day of #ACSFall2023!
Come see #Probius and learn more about how #AI is impacting the #Bioanalytical space with #QES, a bench-top solution that's reagent- and sample prep- less to simplify analytical development​.
Booth 1558, just outside the Expo Theatre.

[Probius @probiusbio]

Need help w/ analytical development? From #smallmolecules to #proteins, #MiniQES's 1-step assay does not require reagents or sample prep. Simple verification and validation. Let's discuss a Proof-of-Principle!
Come by #ACSFall2023 booth #1558

#Probius #Bioanalytical #AI #QES

[Probius @probiusbio]

Applied machine/deep learning & #lifesciences are coming together to transform how we understand & improve health. We want to partner w/ teams focused on building wet/dry lab platforms & novel datasets to disrupt traditional drug discovery processes. https://t.co/vlnkt2DjV5

[Probius @probiusbio]

There’s no doubt AI will not only improve healthcare, but will also cut healthcare costs. @Accenture estimates that AI applications will cut annual US healthcare costs by $150 B by 2026. #Healthcare #AI

[Probius @probiusbio]

Our commercialization will benefit greatly from Janis’ guidance within the biotechnology market and for biochemical applications. John’s insights into the transformational impact that high-fidelity data can have will help fuel the AI revolution from... https://t.co/LUwPvjGk6c

[Probius @probiusbio]

When you’re changing the way #bioanalysis is done through bridging #biology and #ai, you need deep thinkers with deep connections on your BoD.
Probius is proud to add John J. MacWilliams (@Livermore_Comp among others) and Janis Naeve, PhD (@CotaCapital and @amgen Ventures).

[Ann Revell-Pechar @flackflicks]

Ever wondered if it's ever going to be possible to get in front of disease? Help is on the way. Today @probiusbio emerges, and announces John Baldoni as CSO and Juan Cuevas as SVP Mktg & BizDev.
https://t.co/2fVNSGjoz6